ADV422

N/A

Report date: 2022/12/05 14:07:33
NME

Base Information

Drug NameADV422
Drug Alias NameADV-422
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel alpha2/delta subunit 1 antagonists
TargetsVoltage-gated calcium channel alpha2/delta subunit 1
Therapy Area/IndicationsEpilepsy, AbsenceEpilepsies, Partial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdvantx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAdvantx Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsEpilepsy, AbsenceEpilepsies, Partial
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A